Record Financial Results and FRE Growth
Fee-related earnings (FRE) were a record $1.24 billion in 2025, up 12% year over year, with a record FRE margin of 47% (from 46% prior year). Total fee revenues were a record $2.6 billion for the full year, up 10% organic.
Strong Distributable Earnings and Per-Share Metrics
Distributable earnings (DE) for 2025 were $1.7 billion, or $4.20 per share, up 11% year over year; Q4 DE was $436 million ($1.01 per share).
Outstanding Fundraising and Inflows
Inflows totaled $54 billion in 2025, well above the $40 billion target and up 32% year over year; Q4 inflows were $9.2 billion.
Record Deployment and Realizations
Deployments were a record $54 billion in 2025, up more than 25% versus last year; realized proceeds were $34 billion (almost +20% year over year). Q4 realizations for fund investors were $12 billion.
Record AUM and Strong Performance
Assets under management (AUM) reached a record $477 billion, driven by strong investment performance and fundraising. Selected fund performance: latest vintage U.S. Buyout +17% for the year; Japan buyout funds +60% and +30%; European technology fund +20%.
Market-Leading IPO Activity
Since 2024 Carlyle was the number one sponsor globally by IPO proceeds (~$10 billion over two years). Medline IPO raised >$7 billion and traded >50% above IPO price. Multiple region-first/record sponsor-backed IPOs noted (e.g., Rigaku, Hexaware).
Carlyle AlpInvest Outstanding Momentum
AlpInvest had a record year: invested $14 billion, returned >$10 billion, closed largest-ever secondary strategy at $20 billion. AlpInvest FRE was $274 million (+~60% YoY) and DE was $319 million (almost +70% YoY); net accrued carry $656 million (+21% YoY).
Global Credit Strength and CLO Leadership
Global credit FRE was a record $402 million (+21% YoY) with FRE growing at a ~20% organic CAGR over three years. Carlyle priced a record 39 CLOs in 2025, with CLO inflows of $7 billion (+~20% YoY); realized credit losses averaged just 10 bps per year over the past decade.
Wealth Channel Acceleration
Global wealth saw record inflows in 2025, with evergreen wealth AUM nearly doubling year over year. Wealth headcount grew ~50% and Carlyle soft-launched CPAP (private equity solution for individual investors) in the U.S.
Capital Position and Shareholder Returns
Strong balance sheet at year-end with $2 billion cash, >$3 billion investments, nearly $3 billion net accrued carry (up 9% sequential in Q4). Carlyle returned a record $1.2 billion to shareholders via dividends and buybacks in 2025 and returned $18 billion of capital to investors.